US56400P7069 - Common Stock - After market: 4.82 0 (0%)
NASDAQ:MNKD (12/8/2022, 4:58:07 PM)+0.12 (+2.55%)
|GICS Sector||Health Care|
|Earnings (Last)||11-08 2022-11-08/bmo||Earnings (Next)||02-22 2023-02-22|
|Ins Owners||2.62%||Inst Owners||49.36%|
Find more stocks on Nasdaq
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
MannKind Corp. operates as a biopharmaceutical company. The company is headquartered in Danbury, Connecticut and currently employs 348 full-time employees. The company went IPO on 2004-07-28. The firm is focused on the development and commercialization of inhaled therapeutic products for diabetes and orphan lung diseases, such as pulmonary arterial hypertension. The Company’s lead product is Afrezza Inhalation Powder, which is an inhaled insulin indicated to improve glycemic control in adults with diabetes. Afrezza consists of a dry powder formulation of human insulin delivered from a small portable inhaler. AFREZZA utilizes its Technosphere formulation technology. The Technosphere is a drug delivery platform that allow the oral inhalation of a range of therapeutics.
1 Casper Street
Danbury CONNECTICUT 91362
CEO: Michael E. Castagna
Technosphere® Insulin (TI) peaked 30 minutes faster and significantly reduced postprandial glucose excursions (PPGE) at 60 minutes compared to subcutaneous...
MNKD earnings call for the period ending September 30, 2022.
Conference Call to Begin Today at 9:00 a.m. (ET)
Conference Call to Begin Today at 9:00 a.m. (ET)...
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will release its 2022 third quarter...
Here you can normally see the latest stock twits on MNKD, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.